- Abstract submission20 January 2017
- Standard registration13 February 2017
This conference will update you on advances in personalised cancer medicine, focusing on targeted and immunological therapeutic approaches. It will cover the challenges of tumour heterogeneity, drug resistance and the influence of the tumour microenvironment.
The programme will emphasize new in vitro and in vivo experimental models capturing the complexity of human tumours. New therapeutic targets will be discussed, including those from the metabolome and microenvironment. We will also give attention to how advances coming from the laboratory are being implemented in the clinic.
The conference will bring together basic, translational and clinical scientists, as well as physicians engaged in the challenges of personalised medicine, the development of new therapeutics and clinical implementation.